Literature DB >> 24837770

Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides.

S Mugaba1, R Nakiboneka1, M Nanyonjo1, D Bugembe-Lule1, I Kaddu1, B Nanteza1, R Tweyongyere1, P Kaleebu2, J Serwanga3.   

Abstract

OBJECTIVE: Evaluating HIV-1 specific T-cell response in African populations is sometimes compromised by extensive virus diversity and paucity of non-clade B reagents. We evaluated whether consensus group M (ConM) peptides could serve as comparable substitutes for detecting immune responses in clade A and clade D HIV-1 infection.
METHODS: Frequencies, breadths and polyfunctionality (≥ 3 functions: IFN-γ, IL-2, TNF-α and Perforin) of HIV-specific responses utilizing ConM, ConA and ConD Gag and Nef peptides was compared.
RESULTS: Median genetic distances of infecting gag sequences from consensus group M were (8.9%, IQR 8.2-9.7 and 9%, IQR 3.3-10) for consensus A and D, respectively. Of 24 subjects infected with A and D clade virus, Gag responses were detected in comparable proportions of subjects when using ConM peptides 22/24, ConA peptides 17/24, and ConD peptides 21/24; p=0.12. Nef responses were also detected at similar proportions of subjects when using ConM peptides 15/23, ConA peptides 19/23, and ConD peptides 16/23, p=0.39. Virus-specific CD4+ and CD8+ T-cell polyfunctionality were also detected in similar proportions of infected individuals when using different peptide sets.
CONCLUSIONS: These data support the use of consensus group M overlapping peptide sets as reagents for detecting HIV-specific responses in a clade A and D infected population, but underscore the limitations of utilizing these reagents when evaluating the breadth of virus-specific responses.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Group M peptides; HIV-1 diversity; T-cell responses

Mesh:

Substances:

Year:  2014        PMID: 24837770      PMCID: PMC4642333          DOI: 10.1016/j.vaccine.2014.05.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

1.  High degree of inter-clade cross-reactivity of HIV-1-specific T cell responses at the single peptide level.

Authors:  Xu G Yu; Mathias Lichterfeld; Beth Perkins; Elizabeth Kalife; Stanley Mui; Jianping Chen; Michael Cheng; Wenzhen Kang; Galit Alter; Christian Brander; Bruce D Walker; Marcus Altfeld
Journal:  AIDS       Date:  2005-09-23       Impact factor: 4.177

2.  Differential immunogenicity of HIV-1 clade C proteins in eliciting CD8+ and CD4+ cell responses.

Authors:  Danni Ramduth; Polan Chetty; Nolwandle Cyloria Mngquandaniso; Nonhlanhla Nene; Jason Davis Harlow; Isobella Honeyborne; Nelisiwe Ntumba; Sharika Gappoo; Chiara Henry; Prakash Jeena; Marylyn Martina Addo; Marcus Altfeld; Christian Brander; Cheryl Day; Hoosen Coovadia; Photini Kiepiela; Philip Goulder; Bruce Walker
Journal:  J Infect Dis       Date:  2005-09-30       Impact factor: 5.226

3.  Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.

Authors:  Philippa J Easterbrook; Mel Smith; Jane Mullen; Siobhan O'Shea; Ian Chrystie; Annemiek de Ruiter; Iain D Tatt; Anna Maria Geretti; Mark Zuckerman
Journal:  J Int AIDS Soc       Date:  2010-02-03       Impact factor: 5.396

4.  SPICE: exploration and analysis of post-cytometric complex multivariate datasets.

Authors:  Mario Roederer; Joshua L Nozzi; Martha C Nason
Journal:  Cytometry A       Date:  2011-01-07       Impact factor: 4.355

5.  Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?

Authors:  V Novitsky; U R Smith; P Gilbert; M F McLane; P Chigwedere; C Williamson; T Ndung'u; I Klein; S Y Chang; T Peter; I Thior; B T Foley; S Gaolekwe; N Rybak; S Gaseitsiwe; F Vannberg; R Marlink; T H Lee; M Essex
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

6.  Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses.

Authors:  B Julg; K L Williams; S Reddy; K Bishop; Y Qi; M Carrington; P J Goulder; T Ndung'u; B D Walker
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

7.  HIV type 1 vaccines for worldwide use: predicting in-clade and cross-clade breadth of immune responses.

Authors:  Adam C Finnefrock; Xiaomei Liu; David W Opalka; John W Shiver; Danilo R Casimiro; Jon H Condra
Journal:  AIDS Res Hum Retroviruses       Date:  2007-10       Impact factor: 2.205

8.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children.

Authors:  M E Feeney; K A Roosevelt; Y Tang; K J Pfafferott; K McIntosh; S K Burchett; C Mao; B D Walker; P J R Goulder
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

10.  CD8+ T-cell responses to different HIV proteins have discordant associations with viral load.

Authors:  Photini Kiepiela; Kholiswa Ngumbela; Christina Thobakgale; Dhanwanthie Ramduth; Isobella Honeyborne; Eshia Moodley; Shabashini Reddy; Chantal de Pierres; Zenele Mncube; Nompumelelo Mkhwanazi; Karen Bishop; Mary van der Stok; Kriebashnie Nair; Nasreen Khan; Hayley Crawford; Rebecca Payne; Alasdair Leslie; Julia Prado; Andrew Prendergast; John Frater; Noel McCarthy; Christian Brander; Gerald H Learn; David Nickle; Christine Rousseau; Hoosen Coovadia; James I Mullins; David Heckerman; Bruce D Walker; Philip Goulder
Journal:  Nat Med       Date:  2006-12-17       Impact factor: 53.440

View more
  1 in total

1.  Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.

Authors:  Ritah Nakiboneka; Susan Mugaba; Betty O Auma; Christopher Kintu; Christina Lindan; Mary Bridget Nanteza; Pontiano Kaleebu; Jennifer Serwanga
Journal:  Vaccine       Date:  2018-11-17       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.